Cognitive-behavioral therapy for anxiety in children with high-functioning autism: A meta-analysis

Pediatrics

Volumn 132, Issue 5, 2013, Pages

  Sukhodolsky, Denis G ^a   Bloch, Michael H ^a   Panza, Kaitlyn E ^a   Reichow, Brian ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescents; Anxiety; Autism spectrum disorder; Children; Cognitive behavior therapy; Meta analysis; Randomized controlled trial

Indexed keywords

ANXIETY DISORDER; ASPERGER SYNDROME; CLINICAL ASSESSMENT; COGNITIVE THERAPY; EVIDENCE BASED MEDICINE; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; OUTCOME ASSESSMENT; PARENT; PRIORITY JOURNAL; RECREATION; REVIEW; SCORING SYSTEM; SELF REPORT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ANXIETY; AUTISTIC DISORDER; CHILD; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANXIETY; AUTISTIC DISORDER; CHILD; COGNITIVE THERAPY; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84887036660     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-1193     Document Type: Review

References (77)

1. Kanner L. Autistic disturbances of affective contact. Nervous Child. 1943;2:217-250.
2. de Bruin EI, Ferdinand RF, Meester S, de Nijs PFA, Verheij F. High rates of psychiatric co-morbidity in PDD-NOS. J Autism Dev Disord. 2007;37(5):877-886. (Pubitemid 46790785)
3. Leyfer OT, Folstein SE, Bacalman S, et al. Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord. 2006;36(7):849-861. (Pubitemid 44440104)
4. Muris P, Steerneman P, Merckelbach H, Holdrinet I, Meesters C. Comorbid anxiety symptoms in children with pervasive developmental disorders. J Anxiety Disord. 1998;12(4):387-393. (Pubitemid 28396186)
5. Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry. 2008;47(8):921-929.
6. Hallett V, Lecavalier L, Sukhodolsky DG, et al. Exploring the manifestations of anxiety in children with autism spectrum disorders [published online ahead of print February 2013]. J Autism Dev Disord. doi: 10.1007/s10803-013-1775-1.
7. Skokauskas N, Gallagher L. Mental health aspects of autistic spectrum disorders in children. J Intellect Disabil Res. 2012;56(3):248-257.
8. Oswald DP, Sonenklar NA. Medication use among children with autism spectrum disorders. J Child Adolesc Psychopharmacol. 2007;17(3):348-355. (Pubitemid 47067958)
9. Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008;359(26):2753-2766.
10. Buitelaar JK, van der Gaag RJ, van der Hoeven J. Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: results of an open-label study. J Clin Psychiatry. 1998;59(2):56-59. (Pubitemid 28141236)
11. Namerow LB, Thomas P, Bostic JQ, Prince J, Monuteaux MC. Use of citalopram in pervasive developmental disorders. J Dev Behav Pediatr. 2003;24(2):104-108. (Pubitemid 36546777)
12. Martin A, Koenig K, Anderson GM, Scahill L. Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study. J Autism Dev Disord. 2003;33(1):77-85. (Pubitemid 36323142)
13. King BH, Hollander E, Sikich L, et al; STAART Psychopharmacology Network. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry. 2009;66(6):583-590.
14. McCracken JT, McGough J, Shah B, et al; Research Units on Pediatric Psychopharmacology Autism Network. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347(5):314-321. (Pubitemid 34815353)
15. Shea S, Turgay A, Carroll A, et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics. 2004;114(5). Available at: www.pediatrics.org/cgi/content/full/114/5/e634.
16. Marcus RN, Owen R, Kamen L, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2009;48(11):1110-1119.
17. Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics. 2009;124(6):1533-1540.
18. Stigler KA, Diener JT, Kohn AE, et al. Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: A 14-week, prospective, openlabel study. J Child Adolesc Psychopharmacol. 2009;19(3):265-274.
19. McDougle CJ, Stigler KA, Erickson CA, Posey DJ. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. J Clin Psychiatry. 2008;69(suppl 4):15-20.
20. Seligman LD, Ollendick TH. Cognitivebehavioral therapy for anxiety disorders in youth. Child Adolesc Psychiatr Clin N Am. 2011;20(2):217-238.
21. Compton SN, March JS, Brent D, Albano AM V, Weersing R, Curry J. Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: An evidence-based medicine review. J Am Acad Child Adolesc Psychiatry. 2004;43(8):930-959. (Pubitemid 38971716)
22. Kendall PC. Guiding theory for therapy with children and adolescents. In: Kendall PC, ed. Child and Adolescent Therapy: Cognitive- Behavioral Procedures. 3rd ed. New York: Guilford; 2006:3-30.
23. Kendall PC, Hudson JL, Gosch E, Flannery- Schroeder E, Suveg C. Cognitive-behavioral therapy for anxiety disordered youth: A randomized clinical trial evaluating child and family modalities. J Consult Clin Psychol. 2008;76(2):282-297. (Pubitemid 351522262)
24. Kendall PC. Treating anxiety disorders in children: results of a randomized clinical trial. J Consult Clin Psychol. 1994;62(1):100-110. (Pubitemid 24058702)
25. Moree BN, Davis TE III. Cognitive-behavioral therapy for anxiety in children diagnosed with autism spectrum disorders: modification trends. Res Autism Spectr Disord. 2010;4(3):346-354.
26. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12. (Pubitemid 26120810)
27. Lipsey MW, Wilson DB. Practical Meta- Analysis. Thousand Oaks, CA: Sage; 2001.
28. Spence SH. A measure of anxiety symptoms among children. Behav Res Ther. 1998;36 (5):545-566. (Pubitemid 28288652)
29. March J. Manual for the Multidimensional Anxiety Scale for Children (MASC). Toronto, ON: Multi-Health Systems; 1998.
30. Sukhodolsky DG, Scahill L, Gadow KD, et al. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning. J Abnorm Child Psychol. 2008;36(1):117-128. (Pubitemid 351426652)
31. Silverman WK, Albano AM. Anxiety Disorders Interview Schedule for DSM-IV, Child Version. New York: Oxford University Press; 1996.
32. RUPP Anxiety Study Group. The Pediatric Anxiety Rating Scale (PARS): Development and psychometric properties. J Am Acad Child Adolesc Psychiatry. 2002;41(9):1061-1069.
33. Reynolds CR, Richmond BO. What I think and feel: A revised measure of children's manifest anxiety. J Abnorm Child Psychol. 1978;6(2):271-280. (Pubitemid 10191766)
34. Storch EA, Arnold EB, Lewin AB, et al. The effect of cognitive-behavioral therapy versus treatment as usual for anxiety in children with autism spectrum disorders: A randomized, controlled trial. J Am Acad Child Adolesc Psychiatry. 2013;52(2):132-142, e2.
35. Chalfant AM, Rapee R, Carroll L. Treating anxiety disorders in children with high functioning autism spectrum disorders: A controlled trial. J Autism Dev Disord. 2007;37(10):1842-1857. (Pubitemid 47609344)
36. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Metaanalysis. Chichester, West Sussex, UK: John Wiley & Sons; 2009.
37. Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11(2):193-206. (Pubitemid 44001277)
38. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558. (Pubitemid 34746062)
39. Sofronoff K, Attwood T, Hinton S. A randomised controlled trial of a CBT intervention for anxiety in children with Asperger syndrome. J Child Psychol Psychiatry. 2005; 46(11):1152-1160. (Pubitemid 44202673)
40. Wood JJ, Drahota A, Sze K, Har K, Chiu A, Langer DA. Cognitive behavioral therapy for anxiety in children with autism spectrum disorders: A randomized, controlled trial. J Child Psychol Psychiatry. 2009;50(3):224-234.
41. Reaven J, Blakeley-Smith A, Culhane-Shelburne K, Hepburn S. Group cognitive behavior therapy for children with high-functioning autism spectrum disorders and anxiety: A randomized trial. J Child Psychol Psychiatry. 2012;53 (4):410-419.
42. McNally Keehn RH, Lincoln AJ, Brown MZ, Chavira DA. The Coping Cat program for children with anxiety and autism spectrum disorder: A pilot randomized controlled trial. J Autism Dev Disord. 2013;43(1):57-67.
43. White SW, Ollendick T, Albano AM, et al. Randomized controlled trial: Multimodal Anxiety and Social Skill Intervention for adolescents with autism spectrum disorder. J Autism Dev Disord. 2013;43(2):382-394.
44. Sung M, Ooi YP, Goh TJ, et al. Effects of cognitive-behavioral therapy on anxiety in children with autism spectrum disorders: A randomized controlled trial. Child Psychiatry Hum Dev. 2011;42(6):634-649.
45. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA statement. PLoS Med. 2009;6(7): E1000097.
46. Rothstein HR, Sutton AJ, Borenstein M. Publication Bias in Meta-analysis: Prevention, Assessment, and Adjustments. Chichester, West Sussex, UK: John Wiley & Sons; 2005.
47. Sterne JAC, Becker BJ, Egger M. The funnel plot. In: Rothstein HR, Sutton AJ, Boernstein M, eds. Publication Bias in Meta-analysis: Prevention, Assessment, and Adjustments. Chichester, West Sussex, UK: John Wiley & Sons; 2005:75-98.
48. Reynolds S, Wilson C, Austin J, Hooper L. Effects of psychotherapy for anxiety in children and adolescents: A meta-analytic review. Clin Psychol Rev. 2012;32(4):251-262.
49. James A, Soler A, Weatherall R. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev. 2005;4(4):CD004690.
50. Kerns CM, Kendall PC. The presentation and classification of anxiety in autism spectrum disorder. Clin Psychol Sci Pract. 2012;19(4): 323-347.
51. Bodfish JW, Symons FJ, Parker DE, Lewis MH. Varieties of repetitive behavior in autism: comparisons to mental retardation. J Autism Dev Disord. 2000;30(3):237-243.
52. Volkmar F, Cook EH Jr, Pomeroy J, et al. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry. 1999;38(12 suppl. 1): 32S-54S.
53. Ruta L, Mugno D, D'Arrigo VG, Vitiello B, Mazzone L. Obsessive-compulsive traits in children and adolescents with Asperger syndrome. Eur Child Adolesc Psychiatry. 2010;19(1):17-24.
54. Esbensen AJ, Seltzer MM, Lam KSL, Bodfish JW. Age-related differences in restricted repetitive behaviors in autism spectrum disorders. J AutismDev Disord. 2009;39(1):57-66.
55. Bachevalier J, Loveland KA. The orbitofrontal- Amygdala circuit and self-regulation of social-emotional behavior in autism. Neurosci Biobehav Rev. 2006;30(1):97-117. (Pubitemid 41779409)
56. Bellini S. Social skill deficits and anxiety in high-functioning adolescents with autism spectrum disorders. Focus Autism Other Dev Disabil. 2004;19(2):78-86.
57. Chamberlain B, Kasari C, Rotheram-Fuller E. Involvement or isolation? The social networks of children with autism in regular classrooms. J Autism Dev Disord. 2007;37 (2):230-242.
58. Ung D, Arnold EB, De Nadai AS, et al. Interrater reliability of the Anxiety Disorders Interview Schedule for DSM-IV in highfunctioning youth with autism spectrum disorder [published online ahead of print March 27, 2013]. J Dev Phys Disabil.doi: 10.1007/s10882-013-9343-3.
59. Ishikawa SI, Okajima I, Matsuoka H, Sakano Y. Cognitive behavioural therapy for anxiety disorders in children and adolescents: A meta-analysis. Child Adolesc Ment Health. 2007;12(4):164-172. (Pubitemid 47617312)
60. Silverman WK, Pina AA, Viswesvaran C. Evidence-based psychosocial treatments for phobic and anxiety disorders in children and adolescents. J Clin Child Adolesc Psychol. 2008;37(1):105-130.
61. De Los Reyes A, Youngstrom EA, Swan AJ, Youngstrom JK, Feeny NC, Findling RL. Informant discrepancies in clinical reports of youths and interviewers' impressions of the reliability of informants. J Child Adolesc Psychopharmacol. 2011;21(5):417-424.
62. Achenbach TM, McConaughy SH, Howell CT. Child/adolescent behavioral and emotional problems: implications of cross-informant correlations for situational specificity. Psychol Bull. 1987;101(2):213-232.
63. Lopata C, Toomey JA, Fox JD, et al. Anxiety and depression in children with HFASDs: symptom levels and source differences. J Abnorm Child Psychol. 2010;38(6):765-776.
64. Mayes SD, Calhoun SL, Murray MJ, Ahuja M, Smith LA. Anxiety, depression, and irritability in children with autism relative to other neuropsychiatric disorders and typical development. Res Autism Spectr Disord. 2011;5(1):474-485.
65. White SW, Schry AR, Maddox BB. The assessment of anxiety in high-functioning adolescents with autism spectrum disorder. J Autism Dev Disord. 2012;42(6):1138-1145.
66. Russell E, Sofronoff K. Anxiety and social worries in children with Asperger syndrome. Aust N Z J Psychiatry. 2005;39(7):633-638. (Pubitemid 41602549)
67. Mazefsky CA, Kao J, Oswald DP. Preliminary evidence suggesting caution in the use of psychiatric self-report measures with adolescents with high-functioning autism spectrum disorders. Res Autism Spectr Disord. 2011;5(1):164-174.
68. Sze KM, Wood JJ. Enhancing CBT for the treatment of autism spectrum disorders and concurrent anxiety. Behav Cogn Psychother. 2008;36(4):403-409.
69. McNally RJ. Mechanisms of exposure therapy: how neuroscience can improve psychological treatments for anxiety disorders. Clin Psychol Rev. 2007;27(6):750-759. (Pubitemid 46899294)
70. Sukhodolsky DG, Gorman BS, Scahill L, Findley DB, McGuire J. Exposure and response prevention with or without parent management training for children with obsessive-compulsive disorder complicated by disruptive behavior: A multiplebaseline across-responses design study. J Anxiety Disord. 2013;27(3):298-305.
71. Sukhodolsky DG, Golub A, Stone EC, Orban L. Dismantling anger control training for children: A randomized pilot study of social problem-solving versus social skills training components. Behav Ther. 2005;36(1):15-23. (Pubitemid 43150328)
72. Lyneham HJ, Abbott MJ, Wignall A, Rapee RM. The Cool Kids Family Program: Therapist Manual. Sydney, Australia: Macquarie University; 2003.
73. Wood JJ, McLeod BD. Child Anxiety Disorders: A Family-Based Treatment Manual. New York, NY: Norton; 2008.
74. Kendall PC, Hedtke KA. Cognitive- Behavioral Therapy for Anxious Children: Therapist Manual, 3rd ed. Ardmore, PA: Workbook Publishing; 2006.
75. Reaven J, Blakely-Smith A, Nichols S, Hepburn S. Facing Your Fears: Facilitator's Set. Baltimore, MD: Brookes Publishing; 2011.
76. Wood JJ, Drahota A. Behavioral Intervention for Anxiety in Children With Autism. Los Angeles, CA: University of California-Los Angeles; 2005.
77. White SW, Albano AM, Johnson CR, et al. Development of a cognitive-behavioral intervention program to treat anxiety and social deficits in teens with highfunctioning autism. Clin Child Fam Psychol Rev. 2010;13(1):77-90.